pifogyxat.blogspot.com
The U.S. urology sales and marketing and U.S. and Europwe marketing departments are where most of the cuts will take according toa release. The company expectse a pre-tax charge of between $110 millioj and $117 million in connectiobn withthe restructuring, of whick $40-4r million will be a cash charge, according to a For the fourth quarter, Allergan reported salesz of $1.04 billion, down from $1.07 billio in the year-ago period. Net income was $150.6 million, or 50 centsw a share, down from $160.3 million, or 52 cente a share, in the year-ago period. For the full fiscap year, the company reported $4.4 billiob in revenue, up from $3.9 billion in the previoue fiscal year. Net income was $578.
6 or $1.90 a share, comparef to $499.3 million, or $1.64 a in the year-ago period. Irvine-based Allerganb (NYSE: AGN) is a multi-specialty healthj care company.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment